Results
|
1.
|
Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma. [electronic resource] by
- Arnulf, Bertrand
- Pylypenko, Halyna
- Grosicki, Sebastian
- Karamanesht, Ievgenii
- Leleu, Xavier
- van de Velde, Helgi
- Feng, Huaibao
- Cakana, Andrew
- Deraedt, William
- Moreau, Philippe
Producer: 20131210
In:
Haematologica vol. 97
Availability: No items available.
|
|
2.
|
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia. [electronic resource] by
- Kipps, Thomas J
- Eradat, Herbert
- Grosicki, Sebastian
- Catalano, John
- Cosolo, Walter
- Dyagil, Iryna S
- Yalamanchili, Sreeni
- Chai, Akiko
- Sahasranaman, Srikumar
- Punnoose, Elizabeth
- Hurst, Deborah
- Pylypenko, Halyna
Producer: 20160909
In:
Leukemia & lymphoma vol. 56
Availability: No items available.
|
|
3.
|
Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study. [electronic resource] by
- Moreau, Philippe
- Pylypenko, Halyna
- Grosicki, Sebastian
- Karamanesht, Ievgenii
- Leleu, Xavier
- Rekhtman, Grigoriy
- Masliak, Zvenyslava
- Robak, Pawel
- Esseltine, Dixie-Lee
- Feng, Huaibao
- Deraedt, William
- van de Velde, Helgi
- Arnulf, Bertrand
Producer: 20151022
In:
Haematologica vol. 100
Availability: No items available.
|
|
4.
|
Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP [electronic resource] by
- Verhoef, Gregor
- Robak, Tadeusz
- Huang, Huiqiang
- Pylypenko, Halyna
- Siritanaratkul, Noppadol
- Pereira, Juliana
- Drach, Johannes
- Mayer, Jiri
- Okamoto, Rumiko
- Pei, Lixia
- Rooney, Brendan
- Cakana, Andrew
- van de Velde, Helgi
- Cavalli, Franco
Producer: 20180118
In:
Haematologica vol. 102
Availability: No items available.
|
|
5.
|
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study. [electronic resource] by
- Robak, Tadeusz
- Jin, Jie
- Pylypenko, Halyna
- Verhoef, Gregor
- Siritanaratkul, Noppadol
- Drach, Johannes
- Raderer, Markus
- Mayer, Jiri
- Pereira, Juliana
- Tumyan, Gayane
- Okamoto, Rumiko
- Nakahara, Susumu
- Hu, Peter
- Appiani, Carlos
- Nemat, Sepideh
- Cavalli, Franco
Producer: 20190610
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|
|
6.
|
Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study [electronic resource] by
- Robak, Tadeusz
- Huang, Huiqiang
- Jin, Jie
- Zhu, Jun
- Liu, Ting
- Samoilova, Olga
- Pylypenko, Halyna
- Verhoef, Gregor
- Siritanaratkul, Noppadol
- Osmanov, Evgenii
- Pereira, Juliana
- Mayer, Jiri
- Hong, Xiaonan
- Okamoto, Rumiko
- Pei, Lixia
- Rooney, Brendan
- van de Velde, Helgi
- Cavalli, Franco
Producer: 20191231
In:
Leukemia & lymphoma vol. 60
Availability: No items available.
|
|
7.
|
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study. [electronic resource] by
- Gisslinger, Heinz
- Klade, Christoph
- Georgiev, Pencho
- Krochmalczyk, Dorota
- Gercheva-Kyuchukova, Liana
- Egyed, Miklos
- Rossiev, Viktor
- Dulicek, Petr
- Illes, Arpad
- Pylypenko, Halyna
- Sivcheva, Lylia
- Mayer, Jiri
- Yablokova, Vera
- Krejcy, Kurt
- Grohmann-Izay, Barbara
- Hasselbalch, Hans C
- Kralovics, Robert
- Kiladjian, Jean-Jacques
Producer: 20200311
In:
The Lancet. Haematology vol. 7
Availability: No items available.
|
|
8.
|
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. [electronic resource] by
- Moreau, Philippe
- Pylypenko, Halyna
- Grosicki, Sebastian
- Karamanesht, Ievgenii
- Leleu, Xavier
- Grishunina, Maria
- Rekhtman, Grigoriy
- Masliak, Zvenyslava
- Robak, Tadeusz
- Shubina, Anna
- Arnulf, Bertrand
- Kropff, Martin
- Cavet, James
- Esseltine, Dixie-Lee
- Feng, Huaibao
- Girgis, Suzette
- van de Velde, Helgi
- Deraedt, William
- Harousseau, Jean-Luc
Producer: 20110628
In:
The Lancet. Oncology vol. 12
Availability: No items available.
|
|
9.
|
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. [electronic resource] by
- Robak, Tadeusz
- Huang, Huiqiang
- Jin, Jie
- Zhu, Jun
- Liu, Ting
- Samoilova, Olga
- Pylypenko, Halyna
- Verhoef, Gregor
- Siritanaratkul, Noppadol
- Osmanov, Evgenii
- Alexeeva, Julia
- Pereira, Juliana
- Drach, Johannes
- Mayer, Jiri
- Hong, Xiaonan
- Okamoto, Rumiko
- Pei, Lixia
- Rooney, Brendan
- van de Velde, Helgi
- Cavalli, Franco
Producer: 20150316
In:
The New England journal of medicine vol. 372
Availability: No items available.
|
|
10.
|
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study. [electronic resource] by
- Chanan-Khan, Asher
- Cramer, Paula
- Demirkan, Fatih
- Fraser, Graeme
- Silva, Rodrigo Santucci
- Grosicki, Sebastian
- Pristupa, Aleksander
- Janssens, Ann
- Mayer, Jiri
- Bartlett, Nancy L
- Dilhuydy, Marie-Sarah
- Pylypenko, Halyna
- Loscertales, Javier
- Avigdor, Abraham
- Rule, Simon
- Villa, Diego
- Samoilova, Olga
- Panagiotidis, Panagiots
- Goy, Andre
- Mato, Anthony
- Pavlovsky, Miguel A
- Karlsson, Claes
- Mahler, Michelle
- Salman, Mariya
- Sun, Steven
- Phelps, Charles
- Balasubramanian, Sriram
- Howes, Angela
- Hallek, Michael
Producer: 20160628
In:
The Lancet. Oncology vol. 17
Availability: No items available.
|